WHO Study Finds Remdesivir Has ‘Little Or No Effect’ On Preventing Deaths — 10/16/20, 6:15 a.m. ET
The World Health Organization said the antiviral drug remdesivir — one of the many drugs President Donald Trump was given to treat his coronavirus infection — has “little to no effect” on mortality for patients hospitalized with the coronavirus, CNN reported.
WHO looked at four therapeutics in a study covering more than 11,000 coronavirus patients in 30 countries. Along with remdesivir, the study analyzed the use of hydroxychloroquine, a combination of the anti-HIV drugs lopinavir and ritonavir, and interferon.
“For each drug in the study, the effect on mortality was disappointingly unpromising,” WHO said. The study hasn’t been published in a peer-reviewed journal, but WHO published the results itself.
The disappointing result differs from an earlier study in the U.S. that found that remdesivir shortens recovery time by about a third in those hospitalized with serious illness.